Why is TransMedics Group, Inc. ?
- The company has declared positive results for the last 12 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 115.27 MM
- ROCE(HY) Highest at 28.21%
- INVENTORY TURNOVER RATIO(HY) Highest at 4.89 times
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Along with generating 85.80% returns in the last 1 year, the stock has outperformed S&P 500 in the last 3 years, 1 year and 3 months
How much should you buy?
- Overall Portfolio exposure to TransMedics Group, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is TransMedics Group, Inc. for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at USD 115.27 MM
Highest at 28.21%
Highest at 4.89 times
The company hardly has any interest cost
Fallen by -1.34% (YoY
Highest at 5.71 times
Highest at USD 157.37 MM
Highest at USD 43.3 MM
Highest at 27.51 %
Highest at USD 36.18 MM
Highest at USD 34.91 MM
Highest at USD 0.92
Here's what is working for TransMedics Group, Inc.
Operating Cash Flows (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Inventory Turnover Ratio
Net Sales (USD MM)
Net Sales (USD MM)
Operating Profit (USD MM)
Operating Profit to Sales
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
EPS (USD)
Debtors Turnover Ratio
Raw Material Cost as a percentage of Sales
Depreciation (USD MM)






